Cargando…
Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
BACKGROUND: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography. METHODS: A total of 128 CTO patients we...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Akadémiai Kiadó
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044539/ https://www.ncbi.nlm.nih.gov/pubmed/32148912 http://dx.doi.org/10.1556/1646.11.2019.15 |
_version_ | 1783501593571753984 |
---|---|
author | Aktürk, Erdal Aşkın, Lütfü Taşolar, Hakan Kurtoğlu, Ertuğrul Türkmen, Serdar Tanrıverdi, Okan Uzel, Kader Eliz |
author_facet | Aktürk, Erdal Aşkın, Lütfü Taşolar, Hakan Kurtoğlu, Ertuğrul Türkmen, Serdar Tanrıverdi, Okan Uzel, Kader Eliz |
author_sort | Aktürk, Erdal |
collection | PubMed |
description | BACKGROUND: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography. METHODS: A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg(−1) · h(−1) saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg(−1) · h(−1) only during CTO-PCI procedure, which is called as intensive infusion. RESULTS: CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375; p < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN. CONCLUSION: Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure. |
format | Online Article Text |
id | pubmed-7044539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Akadémiai Kiadó |
record_format | MEDLINE/PubMed |
spelling | pubmed-70445392020-03-06 Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions Aktürk, Erdal Aşkın, Lütfü Taşolar, Hakan Kurtoğlu, Ertuğrul Türkmen, Serdar Tanrıverdi, Okan Uzel, Kader Eliz Interv Med Appl Sci Original Paper BACKGROUND: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography. METHODS: A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg(−1) · h(−1) saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg(−1) · h(−1) only during CTO-PCI procedure, which is called as intensive infusion. RESULTS: CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375; p < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN. CONCLUSION: Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure. Akadémiai Kiadó 2019-07-02 2019-06 /pmc/articles/PMC7044539/ /pubmed/32148912 http://dx.doi.org/10.1556/1646.11.2019.15 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated. |
spellingShingle | Original Paper Aktürk, Erdal Aşkın, Lütfü Taşolar, Hakan Kurtoğlu, Ertuğrul Türkmen, Serdar Tanrıverdi, Okan Uzel, Kader Eliz Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
title | Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
title_full | Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
title_fullStr | Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
title_full_unstemmed | Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
title_short | Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
title_sort | evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044539/ https://www.ncbi.nlm.nih.gov/pubmed/32148912 http://dx.doi.org/10.1556/1646.11.2019.15 |
work_keys_str_mv | AT akturkerdal evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions AT askınlutfu evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions AT tasolarhakan evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions AT kurtogluertugrul evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions AT turkmenserdar evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions AT tanrıverdiokan evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions AT uzelkadereliz evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions |